Hosted by the Nolan Family Center for Cardiovascular Health

At the Heart of Cardiovascular Disease Prevention 2025

7th Annual Evening Dinner Symposium
May 8, 2025
Image
An image depicting a CT scan of the heart
05/08/2025 17:00
Days
Hours
Mins
Secs

Until At the Heart of Cardiovascular Disease Prevention 2025 Begins

Details

This evening dinner symposium will educate physicians, advanced care providers and the broader healthcare team on current guidelines and opinion on the identification of risk factors, prevention measures and treatment options for cardiovascular disease. Don't miss out on early bird special pricing! 

Date & Time: Thursday May 8, 2025 | 5:00pm - 8:30pm
Location: Olympic Hills Golf Club | 10625 Mt Curve Rd, Eden Prairie, MN 55347

According to the Centers for Disease Control and Prevention, cardiovascular disease is the leading cause of death in the United States. The aging population, increase in obesity and cardiometabolic disease, ongoing health disparities and the suboptimal control of risk factors will likely exacerbate the incidence of cardiovascular disease in future years. This cardiovascular disease prevention conference will educate physicians, advanced care providers and the broader healthcare team on current guidelines and opinion on the identification of risk factors, prevention measures and treatment options for cardiovascular disease. 

Registration Fees: 
In-Person Early Bird General Admission: $75.00
Webinar Admission: $50.00
Industry Admission: $150.00

Meet the Faculty
An image of Dr. Michael Miedema

Michael Miedema, MD, MPH

Director, Cardiovascular Prevention | Allina Health Minneapolis Heart Institute
Director, Nolan Family Center for Cardiovascular Health | Minneapolis Heart Institute Foundation

Thomas Knickelbine Minneapolis Heart Institute Foundation

Thomas Knickelbine, MD

Senior Consulting Cardiologist; Director, Lipid Research | Allina Health Minneapolis Heart Institute

A photograph of Elizabeth Tuohy, MD

Elizabeth Tuohy, MD

Medical Director, Heart Disease Prevention Clinic | Allina Health Minneapolis Heart Institute - St. Paul

Jonathan Urbach, MD

Jonathan Urbach, MD

Cardiologist | Allina Health Minneapolis Heart Institute

Agenda

5:00pm-6:00pm Registration, Buffet Dinner & Exhibits
6:00pm-6:10pm Welcome (Michael Miedema, MD, MPH)
6:10pm-6:30pm Expanding Choices in Lipid Management (Thomas Knickelbine, MD)
6:30pm-6:50pm Understanding Women's Cardiovascular Disease Risk (Elizabeth Tuohy, MD)
6:50pm-7:10pm Revolutionizing CV Health - The Impact of GLP-1 Medications (Michael Miedema, MD, MPH)
7:10pm-7:30pm AI in Cardiovascular CT - Current State and Future Directions (Jonathan Urbach, MD)
7:30pm-8:00pm Expert Roundtable (Moderated by Michael Miedema, MD, MPH)
8:00pm-8:30pm Exhibits

Accreditation

Allina Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Allina Health designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is designed to meet the Minnesota Board of Nursing continuing education requirements for 2.0 hours of credit.  

 

Learning Objectives

  1. Discuss medications that can be used in addition to statins for LDL lowering.
  2. Outline heart disease pathophysiology and considerations unique to women.
  3. Identify female-specific risk factors for cardiovascular disease.
  4. Recall current information on the role of GLP-1 medications in cardiovascular disease prevention. 
  5. Outline current and future applications of artificial intelligence in cardiovascular CT and its potential impact on patient care and outcomes.

Target Audience

Primary Care, Internal Medicine, Family Medicine, OB/GYN and Cardiology Physicians, Advanced Practice Providers (Nurse Practitioner and Physician Assistants) and other health care professionals on their care teams

Thank You Exhibitors!

Alnylam NewAmsterdam Pharma
Amgen Novartis
BridgeBio Novo Nordisk
CMP Pharma Regeneron
Edwards Lifesciences United Therapeutics
J&J MedTech  
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support lasting change in the lives of individuals we serve and future generations to come.